Olaf Reich Selected Research

Endometrial Stromal Sarcoma

7/2007	Hormonal therapy of endometrial stromal sarcoma.
1/2007	Estrogen sulfotransferase expression in endometrial stromal sarcomas: an immunohistochemical study.
8/2006	Estrogen replacement therapy and tamoxifen are contraindicated in patients with endometrial stromal sarcoma.
7/2005	Hormonal treatment with aromatase inhibitors for patients with endometrial stromal sarcoma.
6/2005	Should lymphadenectomy be performed in patients with endometrial stromal sarcoma?
4/2005	Gonadotropin-releasing hormone receptor expression in endometrial stromal sarcomas: an immunohistochemical study.
2/2005	Is tamoxifen an option for patients with endometrial stromal sarcoma?
1/2004	Aromatase expression in low-grade endometrial stromal sarcomas: an immunohistochemical study.
7/2002	Cytologic diagnosis of low grade endometrial stromal sarcoma by staining for estrogen and progesterone receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olaf Reich Research Topics

Disease

9	Endometrial Stromal Sarcoma 07/2007 - 07/2002
6	Neoplasms (Cancer) 01/2022 - 01/2003
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2019 - 02/2002
2	Uterine Cervical Dysplasia 02/2019 - 01/2014
2	Neoplasm Metastasis (Metastasis) 10/2014 - 01/2007
2	Endometriosis 07/2007 - 01/2004
2	Endometrial Neoplasms (Endometrial Cancer) 01/2007 - 01/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2003 - 03/2002
1	Squamous Intraepithelial Lesions 01/2022
1	Anaplasia 06/2021
1	Margins of Excision 12/2017
1	Condylomata Acuminata (Genital Wart) 01/2017
1	Infections 01/2017
1	Anus Neoplasms (Anal Cancer) 01/2017
1	Vulvar Neoplasms (Vulvar Cancer) 10/2013
1	Actinomycosis 05/2008
1	Chorioamnionitis 11/2006
1	Granulosa Cell Tumor 09/2006
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 10/2005
1	Adenomyosis 01/2004
1	Xanthomatosis (Xanthoma) 01/2004
1	Adenocarcinoma 01/2003
1	Carcinoma (Carcinomatosis) 01/2003
1	Carcinogenesis 03/2002
1	Vulvar Lichen Sclerosus 03/2002

Drug/Important Bio-Agent (IBA)

3	Estrogens (Estrogen)FDA Link 07/2007 - 07/2002
3	Aromatase InhibitorsIBA 07/2007 - 01/2004
3	Tamoxifen FDA LinkGeneric 07/2007 - 02/2005
2	Imiquimod (Aldara)FDA LinkGeneric 01/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 09/2019 - 10/2014
2	Coloring Agents (Dyes)IBA 01/2014 - 01/2004
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2007 - 04/2005
2	EnzymesIBA 01/2007 - 01/2003
2	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 09/2006 - 04/2005
1	GlycogenIBA 06/2021
1	VaccinesIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2008
1	Progestins (Progestagens)IBA 07/2007
1	Steroid Receptors (Steroid Receptor)IBA 07/2007
1	estrone sulfotransferaseIBA 01/2007
1	Oxytocin (Pitocin)FDA LinkGeneric 11/2006
1	AutoantibodiesIBA 10/2005
1	LipidsIBA 01/2004
1	Aromatase (CYP19)IBA 01/2004
1	Monoclonal AntibodiesIBA 01/2004
1	Tryptophan (L-Tryptophan)FDA Link 01/2003
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2003
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2002
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2004
2	Aftercare (After-Treatment) 02/2019 - 12/2017
1	Drug Therapy (Chemotherapy) 07/2007
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 07/2007
1	Estrogen Replacement Therapy 08/2006
1	Lymph Node Excision (Lymph Node Dissection) 06/2005
1	Hysterectomy 02/2002